Experimental Weight-Loss Pill Twice as Effective as Ozempic, Trial Shows : ScienceAlert
An experimental new weight loss pill from Danish pharmaceutical giant Novo Nordisk could be twice as effective as its blockbuster Ozempic and Wegovy jabs, early results from a small trial have suggested, sending the firm's shares soaring.The drug amycretin caused people to lose 13 percent of their body weight over three months, according to the results of a phase one trial announced by the company.Previous trials have found that Novo Nordisk's Ozempic and Wegovy drugs lead to around six percent body weight loss over the…